HOW TOLERABLE IS METHOTREXATE IN THE LONG-TERM USE IN JUVENILE IDIOPATHIC ARTHRITIS (JIA)?

被引：1
|
作者：
Minden, K. [1 ,2 ]
Klotsche, J. [3 ]
Niewerth, M. [3 ]
Zink, A. [1 ]
Seipelt, E. [4 ]
Haas, J. -P. [5 ]
Ganser, G. [6 ]
Horneff, G. [7 ]
机构：
[1] German Rheumatism Res Ctr, Epidemiol Unit, Berlin, Germany
[2] Univ Med Charite, Berlin, Germany
[3] German Rheumatism Res Ctr, Berlin, Germany
[4] Immanuel Krankenhaus, Berlin, Germany
[5] Deutsch Zentrum Kinder & Jugendrheumatol, Garmisch Partenkirchen, Germany
[6] St Josef Stift, Sendenhorst, Germany
[7] Asklepios Kinderklin, St Augustin, Germany
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2015年 / 74卷
关键词：
D O I：
10.1136/annrheumdis-2015-eular.5173
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
FRI0498
引用
收藏
页码：609 / 609
页数：1
相关论文
共 50 条
  • [1] Long-term safety of etanercept and adalimumab compared to methotrexate in patients with juvenile idiopathic arthritis (JIA)
    Klotsche, Jens
    Niewerth, Martina
    Haas, Johannes-Peter
    Huppertz, Hans-Iko
    Zink, Angela
    Horneff, Gerd
    Minden, Kirsten
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 (05) : 855 - 861
  • [2] LONG-TERM SAFETY OF ETANERCEPT AND ADALIMUMAB COMPARED TO METHOTREXATE IN PATIENTS WITH JUVENILE IDIOPATHIC ARTHRITIS (JIA)
    Klotsche, J.
    Niewerth, M.
    Seipelt, E.
    Horneff, G.
    Minden, K.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 114 - 114
  • [3] SAFETY PROFILE OF ETANERCEPT IN LONG-TERM USE IN PATIENTS WITH JUVENILE IDIOPATHIC ARTHRITIS (JIA)
    Klotsche, Jens
    Klein, Ariane
    Niewerth, Martina
    Ganser, Gerd
    Aries, Peer
    Walther, Marisa
    Haas, Peter
    Keysser, Gernot
    Horneff, Gerd
    Minden, Kirsten
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 102 - 102
  • [4] Long-Term Safety of Etanercept in Patients with Juvenile Idiopathic Arthritis (JIA)
    Minden, Kirsten
    Niewerth, Martina
    Klotsche, Jens
    Hammer, Michael
    Haas, Johannes Peter
    Ganser, Gerd
    Horneff, Gerd
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S493 - S493
  • [5] Long-term safety of Etanercept in patients with juvenile idiopathic arthritis (JIA)
    Minden, K.
    Klotsche, J.
    Niewerth, M.
    Horneff, G.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2013, 72 : 13 - 13
  • [6] Etanercept in treatment of juvenile idiopathic arthritis (JIA): Results of long-term study
    Calvo, I
    Ceballos, E
    Soriano, J
    ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 : 495 - 495
  • [7] Therapy Survival and Long-Term Safety of Etanercept in Patients with juvenile idiopathic Arthritis (JIA)
    Klotsche, J.
    Niewerth, M.
    Weber, K.
    Hammer, M.
    Haas, J.
    Horneff, G.
    Minden, K.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2013, 72 : 92 - 93
  • [8] Long-term Outcome of Juvenile Idiopathic Arthritis: From the Methotrexate to the Biologic Era
    Giancane, Gabriella
    Muratore, Valentina
    Marzetti, Valentina
    Quilis, Neus
    Benavente, Belen Serrano
    Bagnasco, Francesca
    Alongi, Alessandra
    Civino, Adele
    Consolaro, Alessandro
    Ravelli, Angelo
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [9] LONG-TERM OUTCOME OF JUVENILE IDIOPATHIC ARTHRITIS: COMPARISON OF BIOLOGIC AND METHOTREXATE ERAS
    Giancane, Gabriella
    Muratore, Valentina
    Marzetti, Valentina
    Marti, Neus Quilis
    Benavente, Belen Serrano
    Bagnasco, Francesca
    Alongi, Alessandra
    Civino, Adele
    Quartulli, Lorenzo
    Consolaro, Alessandro
    Ravelli, Angelo
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 623 - 624
  • [10] Methotrexate (MTX) Toxicity Surveillance in Juvenile Idiopathic Arthritis (JIA)
    Kocharla, Lakshmi P.
    Taylor, Janalee
    Weiler, Tracy
    Luggen, Michael
    Brunner, Hermine
    ARTHRITIS AND RHEUMATISM, 2008, 58 (12): : 3986 - 3986
12345